ELDN ELEDON PHARMACEUTICALS INC
FollowCOM (common), issuer CIK 1404281
Filings received so far for Q3 2026: 7 13F filers report a position in ELDN shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Everhart Financial Group, Inc. | 10,000 | $25.3K | <0.01% | 0 | 13F-HRTimeline |
| GK Wealth Management LLC | 7,987 | $20.2K | 0.01% | -3,500 | 13F-HRTimeline |
| GAMMA Investing LLC | 1,709 | $4.32K | <0.01% | +521 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 1,305 | $3.3K | <0.01% | 0 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 453 | $1.15K | <0.01% | -184 | 13F-HRTimeline |
| Planning Strategies Inc. | 181 | $458 | <0.01% | 0 | 13F-HRTimeline |
| Byrne Asset Management LLC | 1 | $2 | <0.01% | 0 | 13F-HRTimeline |